YOUR VYZULTA TREATMENT GUIDE. Please see Important Safety Information on pages 1, 9, 10, 17 and 18. Please see accompanying Prescribing Information.

Size: px
Start display at page:

Download "YOUR VYZULTA TREATMENT GUIDE. Please see Important Safety Information on pages 1, 9, 10, 17 and 18. Please see accompanying Prescribing Information."

Transcription

1 YOUR VYZULTA TREATMENT GUIDE Please see Important Safety Information on pages 1, 9, 10, 17 and 18. Please see accompanying Prescribing Information.

2 INDICATION VYZULTA TM (latanoprostene bunod ophthalmic solution), 0.024%, is used to lower intraocular (eye) pressure in patients with open-angle glaucoma or ocular hypertension. IMPORTANT SAFETY INFORMATION Brown color, or increased brown color, of the iris can occur, which may be permanent. Darkening of the eyelid skin may also occur, which is usually reversible after VYZULTA treatment is discontinued. UNDERSTANDING GLAUCOMA WHAT IS OPEN-ANGLE GLAUCOMA? Open-angle glaucoma is a disease that gradually causes vision loss and may lead to blindness. It occurs when the fluid in one or both of your eyes does not drain properly. This increases the pressure in your eye, which may damage the optic nerve. EYE WITH GLAUCOMA Drainage Canal Blocked Increased Pressure Damage to the Optic Nerve While there is no way to reverse vision loss, early detection and treatment can help preserve sight. Please see additional Important Safety Information on pages 9, 10, 17 and 18. Please see accompanying Prescribing Information. 2

3 HOW MANY PEOPLE HAVE OPEN-ANGLE GLAUCOMA? Open-angle glaucoma is the most common form of glaucoma. Based on a 2013 estimate, more than 44 million people globally have open-angle glaucoma WHAT ARE THE SIGNS AND SYMPTOMS OF GLAUCOMA? Open-angle glaucoma does not have any early warning signs or symptoms. Over time, people with glaucoma will slowly begin to lose peripheral (side) vision. This can be hard to detect, so many people do not notice any vision changes until the disease has become more advanced. If left untreated, people with glaucoma may develop a visual disability and, eventually, blindness. Normal vision Vision with glaucoma While there is no cure for glaucoma and no way to reverse vision loss, early detection and treatment can help preserve sight. 4

4 UNDERSTANDING OCULAR HYPERTENSION WHAT IS OCULAR HYPERTENSION? Ocular hypertension is the medical term used when the pressure in the eye is higher than normal. It is caused when the fluid in the eye does not drain properly. OCULAR HYPERTENSION AND GLAUCOMA People with ocular hypertension may be at a higher risk of glaucoma and should be monitored carefully. Lowering eye pressure in people with glaucoma may slow or prevent vision loss. WHAT ARE THE SIGNS AND SYMPTOMS OF OCULAR HYPERTENSION? There are usually no signs or symptoms of ocular hypertension. It can be detected via routine testing by an eye care professional. It s important to remember to get your eyes tested by an eye care professional. Decreasing the pressure in the eye reduces the risk of vision loss from glaucoma. Please see Important Safety Information on pages 1, 9, 10, 17 and 18. Please see accompanying Prescribing Information. 6

5 WHAT IS VYZULTA? VYZULTA is a prostaglandin analog that may help reduce intraocular (eye) pressure in people with open-angle glaucoma or ocular hypertension. HOW DOES VYZULTA WORK? VYZULTA helps lower intraocular pressure by increasing drainage of fluid from the eye. It is believed to work through two different pathways in the eye. Lowering intraocular pressure can help reduce the risk of vision loss due to glaucoma. Please see Important Safety Information on pages 1, 9, 10, 17 and 18. Please see accompanying Prescribing Information. 8

6 POSSIBLE SIDE EFFECTS WHEN TO CALL YOUR DOCTOR The most common side effects seen in studies were eye redness, eye irritation, eye pain, and pain after putting the drops in your eye. These are not all of the possible side effects. INCREASED BROWN COLOR Brown color, or increased brown color, of the iris can occur, which may be permanent. Darkening of the eyelid skin may also occur, which is usually reversible after VYZULTA treatment is discontinued. IMMEDIATELY SEEK YOUR DOCTOR S ADVICE CONCERNING THE CONTINUED USE OF VYZULTA IF YOU: Experience any change in your eye Have any eye condition that develops Experience any sudden change in your vision or any eye side effects Have eye surgery EYELASH CHANGES Gradual changes to eyelashes may occur, including increased length, thickness, color, number of eyelashes and/or direction of eyelash growth. These changes may result in a difference in appearance of each eye. These changes are usually reversible after VYZULTA treatment is discontinued. Please see additional Important Safety Information on pages 17 and 18. Please see accompanying Prescribing Information. 10

7 APPLYING YOUR EYE DROPS Step 1: Wash your hands. X HOW DO I ADMINISTER VYZULTA? VYZULTA should be used once daily at night. Do not administer VYZULTA more than once daily. IMPORTANT SAFETY INFORMATION Avoid touching the tip of the container to the eye or any other surface, including a finger, in order to avoid contamination of the solution by bacteria. Serious damage to the eye and possible loss of vision may result from using contaminated solutions. The Pocket Step 2: Tilt your head back. Gently pull your lower eyelid down to form a pocket for the drop. Step 3: Administer one drop of VYZULTA into the pocket of the eye(s) with glaucoma. Step 4: Keep your eyes closed and gently press on the inner part of the eye for 30 seconds to keep VYZULTA in contact with the eye for longer. Please see additional Important Safety Information on pages 1, 9, 10, 17 and 18. Please see accompanying Prescribing Information. 12

8 COMMON ADMINISTRATION AND STORAGE QUESTIONS HOW DO I STORE VYZULTA? Store unopened bottles in a refrigerator. Once a bottle is opened, it may be stored at room temperature for up to eight weeks. Do not freeze bottles of VYZULTA. CAN I USE VYZULTA IF I WEAR CONTACT LENSES? If you wear contact lenses, remove them prior to administering VYZULTA. After administering VYZULTA, wait 15 minutes before reinserting your contact lenses. WHAT IF I USE OTHER EYE DROPS? If you are using other eye drops in addition to VYZULTA, wait 5 minutes between using each type of eye drop. Unopened refrigerated (36 F-46 F) Opened room temperature (36 F-77 F) Please see Important Safety Information on pages 1, 9, 10, 17 and 18. Please see accompanying Prescribing Information. 14

9 NOTES ACCESS PROGRAM Talk to your doctor about the cost savings program available for eligible patients from Bausch + Lomb * Learn how the Bausch + Lomb Access Program can help eligible patients save on your next prescription * * Terms and Conditions apply and can be found at Please see Important Safety Information on pages 17 and 18. Please see accompanying Prescribing Information. 16

10 INDICATION VYZULTA TM (latanoprostene bunod ophthalmic solution), 0.024%, is used to lower intraocular (eye) pressure in patients with open-angle glaucoma or ocular hypertension. IMPORTANT SAFETY INFORMATION Brown color, or increased brown color, of the iris can occur, which may be permanent. Darkening of the eyelid skin may also occur, which is usually reversible after VYZULTA treatment is discontinued. Gradual changes to eyelashes may occur, including increased length, thickness, color, number of eyelashes and/or direction of eyelash growth. These changes may result in a difference in appearance of each eye. These changes are usually reversible after VYZULTA treatment is discontinued. IMPORTANT SAFETY INFORMATION (CONTINUED) Avoid touching the tip of the container to the eye or any other surface, including a finger, in order to avoid contamination of the solution by bacteria. Serious damage to the eye and possible loss of vision may result from using contaminated solutions. Tell your doctor immediately about any change in your eye, any eye condition that develops, any sudden change in your vision, any eye side effects, or if you have eye surgery. Remove contact lenses before putting VYZULTA in your eyes. Lenses may be reinserted 15 minutes later. If you are using other eye drops in addition to VYZULTA, wait 5 minutes between using each type of eye drop. The most common side effects seen in studies were eye redness, eye irritation, eye pain, and pain after putting the drops in your eye. Please see accompanying Prescribing Information. 18

11 VYZULTA and the V design are trademarks of Bausch & Lomb Incorporated or its affiliates Bausch & Lomb Incorporated. All rights reserved. VYZ.0069.USA.17

PATIENT GUIDE TO LUMIGAN 0.01%

PATIENT GUIDE TO LUMIGAN 0.01% Treatment Tracker enclosed PATIENT GUIDE TO LUMIGAN 0.01% LUMIGAN (bimatoprost ophthalmic solution) 0.01% is used for the treatment of high eye pressure, also called intraocular pressure (IOP), in people

More information

TREATMENT TRACKER Indication LUMIGAN (bimatoprost ophthalmic solution) 0.01% is used for the reduction of high eye pressure, also called intraocular pressure (IOP), in people with open-angle glaucoma or

More information

LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml)

LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml) LUMIGAN EYE DROPS (bimatoprost 0.3 mg per ml) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about LUMIGAN eye drops. It does not contain all the available

More information

APO-Latanoprost Contains the active ingredient latanoprost

APO-Latanoprost Contains the active ingredient latanoprost APO-Latanoprost Contains the active ingredient latanoprost Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet Read this leaflet carefully before

More information

WORLD GLAUCOMA WEEK What is Glaucoma? Can I develop glaucoma if I have increased eye pressure?

WORLD GLAUCOMA WEEK What is Glaucoma? Can I develop glaucoma if I have increased eye pressure? WORLD GLAUCOMA WEEK What is Glaucoma? Glaucoma is a group of diseases that damage the optic nerve and can result in gradual vision loss and blindness. However, with early detection and treatment, you can

More information

N W KNOW. What You Need to Know. What You Know About Glaucoma Could Save Your Sight

N W KNOW. What You Need to Know. What You Know About Glaucoma Could Save Your Sight What You Need to Know is the second leading cause of blindness around the world, so it is important to understand its significance and treatment options. While glaucoma is not curable, there are several

More information

PRESCRIBING INFORMATION

PRESCRIBING INFORMATION PRESCRIBING INFORMATION OPTIMYXIN Gramicidin and Polymyxin B Sulfate Oto-Ophthalmic Solution sterile Eye/Ear Drops Antibiotic Sandoz Canada Inc. Date of Revision: November 25, 2015 145 Jules-Léger Boucherville,

More information

Get a grip on your glaucoma Booklet 1

Get a grip on your glaucoma Booklet 1 Information for Patients Glaucoma services Welcome! Get a grip on your glaucoma Booklet 1 Group-based Glaucoma information Course Session 1 What happens in session 1? Finding out what questions you have

More information

Glaucoma. What is glaucoma? Eye Words to Know. What causes glaucoma?

Glaucoma. What is glaucoma? Eye Words to Know. What causes glaucoma? 2014 2015 Glaucoma What is glaucoma? Glaucoma is a disease that damages your eye s optic nerve. It usually happens when fluid builds up in the front part of your eye. That extra fluid increases the pressure

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET SCHEDULING STATUS Schedule 4 Proprietary name, Strength and Pharmaceutical Form LUMIGAN 0,03 % Eye Drops (each ml contains bimatoprost 0,3 mg) Read all of this leaflet

More information

CONSUMER INFORMATION. Sandoz Travoprost / Timolol PQ ophthalmic solution travoprost and timolol ophthalmic solution with POLYQUAD * as preservative

CONSUMER INFORMATION. Sandoz Travoprost / Timolol PQ ophthalmic solution travoprost and timolol ophthalmic solution with POLYQUAD * as preservative CONSUMER INFORMATION Pr Sandoz Travoprost / Timolol PQ ophthalmic solution travoprost and timolol ophthalmic solution with POLYQUAD * as preservative This leaflet is designed specifically for Consumers.

More information

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops Page 1 of 6 SCHEDULING STATUS Schedule 4 PATIENT INFORMATION LEAFLET PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops Read all of this leaflet carefully

More information

Ophthalmology. Glaucoma

Ophthalmology. Glaucoma Ophthalmology Glaucoma The Ophthalmology service offers the latest and most comprehensive eye care for patients. With a dedicated team of eye surgeons and consultants, we treat vision problems ranging

More information

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost Package Leaflet: Information for the user LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost Read all of this leaflet carefully before you start using this medicine because it

More information

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate Package leaflet: Information for the user PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate Read all of this leaflet carefully before you start using this medicine because it contains important

More information

Package leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate

Package leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate Package leaflet: Information for the patient Brimonidine Biogaran 2 mg/ml eye drops, solution brimonidine tartrate Read all of this leaflet carefully before you start using this medicine because it contains

More information

Patient & Family Guide. Glaucoma Management.

Patient & Family Guide. Glaucoma Management. Patient & Family Guide Glaucoma Management 2018 www.nshealth.ca Glaucoma Management What is glaucoma? Your eyes are filled with a fluid made by the ciliary body (1). This fluid flows through the pupil

More information

Glaucoma What You Should Know

Glaucoma What You Should Know Glaucoma What You Should Know U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Eye Institute The National Eye Institute (NEI) conducts and supports research that leads

More information

TOBREX TM EYE DROPS and EYE OINTMENT 0.3%

TOBREX TM EYE DROPS and EYE OINTMENT 0.3% TOBREX TM EYE DROPS and EYE OINTMENT 0.3% Tobramycin Consumer Medicine Information What is in this leaflet Read this leaflet carefully before you start to use Tobrex Eye Drops and Eye Ointment. This leaflet

More information

Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin

Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution Levofloxacin Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr IOPIDINE 1% Apraclonidine Ophthalmic Solution, USP Read this carefully before you start taking IOPIDINE 1% and each

More information

ENIDIN EYE DROPS [brimonidine tartrate]

ENIDIN EYE DROPS [brimonidine tartrate] ENIDIN EYE DROPS [brimonidine tartrate] Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ENIDIN eye drops, including how to use the eye It does not

More information

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate Package leaflet: Information for the user PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate Read all of this leaflet carefully before you start using this medicine

More information

Package leaflet: Information for the user. Xalatan 50 micrograms/ml Eye drops, solution Latanoprost

Package leaflet: Information for the user. Xalatan 50 micrograms/ml Eye drops, solution Latanoprost Package leaflet: Information for the user Xalatan 50 micrograms/ml Eye drops, solution Latanoprost Read all of this leaflet carefully before you start using this medicine because it contains important

More information

MURINE HAYFEVER RELIEF 2% W/V EYE DROPS Sodium Cromoglicate

MURINE HAYFEVER RELIEF 2% W/V EYE DROPS Sodium Cromoglicate MURINE HAYFEVER RELIEF 2% W/V EYE DROPS Sodium Cromoglicate Read this leaflet carefully before you start using this medicine. This medicine is available without a prescription, however you still need to

More information

ZADITEN Eye Drops 1.0%

ZADITEN Eye Drops 1.0% ZADITEN Eye Drops 1.0% Ketotifen Consumer Medicine Information What is in this leaflet Please read this leaflet carefully before you use Zaditen Eye Drops. This leaflet answers some common questions about

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. XIIDRA TM* Lifitegrast Ophthalmic Solution 5%

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. XIIDRA TM* Lifitegrast Ophthalmic Solution 5% READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION XIIDRA TM* Lifitegrast Ophthalmic Solution 5% Read this carefully before you start taking XIIDRA and each time you get

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET SCHEDULING STATUS Schedule 4 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM PRED FORTE Sterile Eye Suspension, prednisolone acetate 10 mg/ml sterile eye suspension

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET Page 1 PATIENT INFORMATION LEAFLET Please read this leaflet carefully before using COMBIGAN. Keep this leaflet. You may need to read it again. If you have any further questions, please ask your doctor

More information

Written by Administrator Wednesday, 13 January :27 - Last Updated Thursday, 21 January :34

Written by Administrator Wednesday, 13 January :27 - Last Updated Thursday, 21 January :34 angle closure glaucoma A type of glaucoma caused by a sudden and severe rise in eye pressure. Occurs when the pupil enlarges too much or too quickly, and the outer edge of the iris blocks the eye s drainage

More information

MAINTAINING COMPLIANCE IN GLAUCOMA PATIENTS. by : Abdalla El-Sawy, M.D. Professor of Ophthalmology, Benha Faculty of Medicine.

MAINTAINING COMPLIANCE IN GLAUCOMA PATIENTS. by : Abdalla El-Sawy, M.D. Professor of Ophthalmology, Benha Faculty of Medicine. MAINTAINING COMPLIANCE IN GLAUCOMA PATIENTS by : Abdalla El-Sawy, M.D. Professor of Ophthalmology, Benha Faculty of Medicine. The problem is especially critical for eye doctors who manage patients with

More information

Ophthalmology Department. 2009, The Permanente Medical Group, Inc. All rights reserved, Ophthalmology Department.

Ophthalmology Department. 2009, The Permanente Medical Group, Inc. All rights reserved, Ophthalmology Department. Glaucoma: Title of article Trabeculectomy is Ahmed positioned Valve here POST-SURGICAL SUB TITLE POSITIONED INSTRUCTIONS HERE These instructions are for patients recovering from one of the following eye

More information

PRESCRIBING INFORMATION AND CONSUMER INFORMATION ISOPTO * CARPINE. pilocarpine hydrochloride ophthalmic solution, USP.

PRESCRIBING INFORMATION AND CONSUMER INFORMATION ISOPTO * CARPINE. pilocarpine hydrochloride ophthalmic solution, USP. PRESCRIBING INFORMATION AND CONSUMER INFORMATION Pr ISOPTO * CARPINE pilocarpine hydrochloride ophthalmic solution, USP 1%, 2% and 4% w/v Parasympathomimetic Alcon Canada Inc. 2665 Meadowpine Blvd. Mississauga,

More information

Dorzolamide 20 mg/ml Eye Drops, Solution

Dorzolamide 20 mg/ml Eye Drops, Solution PACKAGE LEAFLET: INFORMATION FOR THE USER Dorzolamide 20 mg/ml Eye Drops, Solution (Dorzolamide hydrochloride) Read all of this leaflet carefully before you start using this medicine because it contains

More information

Ophthalmology. Ophthalmology Services

Ophthalmology. Ophthalmology Services Ophthalmology Ophthalmology Services The Ophthalmology service offers the latest and most comprehensive eye care for patients. With a dedicated team of eye surgeons and consultants, we treat vision problems

More information

Package leaflet: Information for the user. Latanoprost Pfizer 50 micrograms/ml Eye drops, solution Latanoprost

Package leaflet: Information for the user. Latanoprost Pfizer 50 micrograms/ml Eye drops, solution Latanoprost Package leaflet: Information for the user Latanoprost Pfizer 50 micrograms/ml Eye drops, solution Latanoprost Read all of this leaflet carefully before you start using this medicine because it contains

More information

Package Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone

Package Leaflet - Information for the User. TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone Package Leaflet - Information for the User TOBRADEX 3 mg/ml/1 mg/ml Eye Drops, Suspension Tobramycin and Dexamethasone Read all of this leaflet carefully before you start using this medicine because it

More information

GENERAL INFORMATION GLAUCOMA GLAUCOMA

GENERAL INFORMATION GLAUCOMA GLAUCOMA GENERAL INFORMATION GLAUCOMA GLAUCOMA WHAT IS GLAUCOMA? Glaucoma is commonly known as the sneak thief of sight because it can cause irreversible vision loss without any obvious symptoms. The term glaucoma

More information

DUOTRAV Eye Drops travoprost 0.004% and timolol 0.5%

DUOTRAV Eye Drops travoprost 0.004% and timolol 0.5% DUOTRAV Eye Drops travoprost 0.004% and timolol 0.5% Alcon (Australia) Pty Ltd Consumer Medicine Information What is in this Leaflet This leaflet answers some common questions about DUOTRAV Eye Drops.

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone

PACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone PACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You

More information

BrinzoQuin Eye Drops 1.0%

BrinzoQuin Eye Drops 1.0% BrinzoQuin Eye Drops 1.0% Brinzolamide Consumer Medicine Information What Is In This Leaflet Read this leaflet carefully before you start to use BrinzoQuin Eye Drops. This leaflet has been written to answer

More information

TENOPT timolol maleate

TENOPT timolol maleate TENOPT timolol maleate Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about It does not contain all the available information. It does not take the place

More information

CILOXAN TM Eye Drops 0.3%

CILOXAN TM Eye Drops 0.3% CILOXAN TM Eye Drops 0.3% ciprofloxacin hydrochloride CONSUMER MEDICINE INFORMATION What is in this leaflet Read this leaflet carefully before you start to use Ciloxan Eye Drops. This leaflet answers some

More information

What Maxitrol Eye Drops is used for

What Maxitrol Eye Drops is used for MAXITROL Dexamethasone, Neomycin and Polymyxin B CONSUMER MEDICINE INFORMATION What is in this leaflet Read this leaflet carefully before you start to use This leaflet answers some common questions about

More information

ISOPTO CARPINE Eye Drops

ISOPTO CARPINE Eye Drops ISOPTO CARPINE Eye Drops 1%, 2% and 4% Pilocarpine hydrochloride Consumer Medicine Information What is in this leaflet Please read this leaflet carefully before you use any ISOPTO CARPINE Eye Drops. This

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)

PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol) PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol) Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may

More information

AZOPT EYE DROPS 1% What is in this leaflet. Before you use Azopt. What Azopt is used for. Brinzolamide. Consumer Medicine Information.

AZOPT EYE DROPS 1% What is in this leaflet. Before you use Azopt. What Azopt is used for. Brinzolamide. Consumer Medicine Information. Brinzolamide Consumer Medicine Information What is in this leaflet Read this leaflet carefully before you start to use Azopt Eye Drops. This leaflet answers some common questions about Azopt. It does not

More information

CONSUMER MEDICINE INFORMATION

CONSUMER MEDICINE INFORMATION CONSUMER MEDICINE INFORMATION Arrow Dortim Dorzolamide 2% and Timolol 0.5% Eye Drops, Solution What is in this leaflet This leaflet answers some common questions about ARROW-DORTIM. It does not contain

More information

SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM

SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM Page 1 of 5 SCHEDULING STATUS Schedule 4 PROPRIETARY NAME AND DOSAGE FORM FML Liquifilm Sterile Eye Suspension COMPOSITION FML Liquifilm Sterile Eye Suspension contains: Fluorometholone 1,0 mg/ml Liquifilm

More information

ALPHAGAN EYE DROPS BRIMONIDINE TARTRATE

ALPHAGAN EYE DROPS BRIMONIDINE TARTRATE PACKAGE LEAFLET: INFORMATION FOR THE USER ALPHAGAN EYE DROPS BRIMONIDINE TARTRATE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which

More information

TIMALEN 0.5% eye drops

TIMALEN 0.5% eye drops PACKAGE LEAFLET: INFORMATION FOR THE USER TIMALEN 0.5% eye drops TIMOLOL (AS TIMOLOL MALEATE) This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET ENFLUAT 0.4 % Sterile Eye Drops Applied dropwise to the eye. PATIENT INFORMATION LEAFLET Drug substance: Each 1ml contains 4 mg ketorolac tromethamine. Excipient(s): Benzalconium chloride, sodium chloride,

More information

Pilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride

Pilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER Pilocarpine 2% w/v Eye Drops, solution Pilocarpine 4% w/v Eye Drops, solution Pilocarpine Hydrochloride (Referred to as Pilocarpine Eye Drops in this leaflet)

More information

LATANOPROST-TIMOLOL ALPHAPHARM 50/5 eye drops contains the active ingredients latanoprost and timolol (as maleate)

LATANOPROST-TIMOLOL ALPHAPHARM 50/5 eye drops contains the active ingredients latanoprost and timolol (as maleate) eye drops contains the active ingredients latanoprost and timolol (as maleate) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about. It does not contain

More information

Understanding Glaucoma

Understanding Glaucoma Understanding Glaucoma What is glaucoma? Glaucoma is the name for a group of eye conditions in which the optic nerve is damaged at the point at which it leaves the eye. As the diagram below shows, this

More information

glaucoma a closer look

glaucoma a closer look 0AMERICAN ACADEMY OF OPHTHALMOLOGY The Eye M.D. Association 2012-2013 glaucoma a closer look WHAT IS GLAUCOMA? < Glaucoma is a disease of the optic nerve the part of the eye that carries the images we

More information

Factsheet. Glaucoma. Are there different types of glaucoma? Yes. There are four main types.

Factsheet. Glaucoma. Are there different types of glaucoma? Yes. There are four main types. What is glaucoma? Glaucoma is the name for a group of eye conditions in which the optic nerve is damaged at the point where it leaves the eye. This nerve carries information from the light sensitive layer

More information

MAXIDEX Eye Drops 0.1%

MAXIDEX Eye Drops 0.1% MAXIDEX Eye Drops 0.1% Dexamethasone CONSUMER MEDICINE INFORMATION What is in this leaflet Read this leaflet carefully before you start to use Maxidex Eye Drops. This leaflet answers some common questions

More information

Patient Information COSOPT PF (CO-sopt PEA EHF) (dorzolamide hydrochloride-timolol maleate ophthalmic solution) 2%/0.5%

Patient Information COSOPT PF (CO-sopt PEA EHF) (dorzolamide hydrochloride-timolol maleate ophthalmic solution) 2%/0.5% Patient Information COSOPT PF (CO-sopt PEA EHF) (dorzolamide hydrochloride-timolol maleate ophthalmic solution) 2%/0.5% Read this information before you start using COSOPT PF and each time you get a refill.

More information

Glaucoma Intraocular Pressure What Will I Notice?

Glaucoma Intraocular Pressure What Will I Notice? Glaucoma Glaucoma is the name given to a group of eye conditions in which the optic nerve at the back of the eye is slowly damaged. The diagnosis of glaucoma is made when your optometrist or ophthalmologist

More information

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RELESTAT, epinastine hydrochloride 0,5 mg/ml, eye drops

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RELESTAT, epinastine hydrochloride 0,5 mg/ml, eye drops Page 1 of 5 SCHEDULING STATUS Schedule 2 PATIENT INFORMATION LEAFLET PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM RELESTAT, epinastine hydrochloride 0,5 mg/ml, eye drops Read all of this leaflet

More information

Proposed PIL NL/H/0653/001/IB/024/G. MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate

Proposed PIL NL/H/0653/001/IB/024/G. MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate Proposed PIL NL/H/0653/001/IB/024/G PACKAGE LEAFLET: INFORMATION FOR THE USER MONOFREE DEXAMETHASON 1 mg/ml, eye drops, solution in single-dose container Dexamethasone phosphate Read all of this leaflet

More information

Package leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin

Package leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin Package leaflet: Information for the patient Verkazia 1 mg/ml eye drops emulsion ciclosporin Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

[TRAVOPROST] 40 MICROGRAMS/ML, EYE DROPS, SOLUTION RISK MANAGEMENT PLAN. TRAVOPR-v

[TRAVOPROST] 40 MICROGRAMS/ML, EYE DROPS, SOLUTION RISK MANAGEMENT PLAN. TRAVOPR-v [TRAVOPROST] 40 MICROGRAMS/ML, EYE DROPS, SOLUTION RISK MANAGEMENT PLAN TRAVOPR-v2-270214 VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology Studies estimated that 3-6 million people

More information

TOBRADEX TM Eye Drops

TOBRADEX TM Eye Drops TOBRADEX TM Eye Drops Tobramycin and Dexamethasone CONSUMER MEDICINE INFORMATION What is in this leaflet Read this leaflet carefully before you start to use Tobradex Eye This leaflet answers some common

More information

Package leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin

Package leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin Package leaflet: Information for the patient IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

DUOTRAV Eye Drops travoprost 0.004% and timolol 0.5% Consumer Medicine Information

DUOTRAV Eye Drops travoprost 0.004% and timolol 0.5% Consumer Medicine Information DUOTRAV travoprost 0.004% and timolol 0.5% Consumer Medicine Information What is in this Leaflet Read this leaflet carefully before you start to use DuoTrav Eye This leaflet answers some common questions

More information

Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac

Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac Package leaflet: Information for the user NEVANAC 1 mg/ml eye drops, suspension Nepafenac Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

TRAVATAN Eye Drops 0.004% travoprost

TRAVATAN Eye Drops 0.004% travoprost Eye Drops 0.004% travoprost Consumer Medicine Information What is in this leaflet Read this leaflet carefully before you start to use Travatan Eye Drops. This leaflet answers some common questions about

More information

Primary Angle Closure Glaucoma

Primary Angle Closure Glaucoma www.eyesurgeonlondon.co.uk Primary Angle Closure Glaucoma What is Glaucoma? Glaucoma is a condition in which there is damage to the optic nerve. This nerve carries visual signals from the eye to the brain.

More information

Frequently Asked Questions about General Ophthalmology:

Frequently Asked Questions about General Ophthalmology: 1. Normal Eye Structure The eye is a slightly asymmetrical globe, about an inch in diameter. The parts of the eye include: Cornea (a clear dome over the iris), Iris (the pigmented part); Pupil (the black

More information

ACULAR EYE DROPS 5 mg/ml Eye Drops

ACULAR EYE DROPS 5 mg/ml Eye Drops ACULAR EYE DROPS 5 mg/ml Eye Drops (ketorolac trometamol) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ACULAR eye drops, including how to use the

More information

PRESCRIBING INFORMATION WITH CONSUMER INFORMATION MYDRIACYL. tropicamide ophthalmic solution, USP. 0.5% and 1% w/v.

PRESCRIBING INFORMATION WITH CONSUMER INFORMATION MYDRIACYL. tropicamide ophthalmic solution, USP. 0.5% and 1% w/v. PRESCRIBING INFORMATION WITH CONSUMER INFORMATION Pr MYDRIACYL tropicamide ophthalmic solution, USP 0.5% and 1% w/v Anticholinergic Alcon Canada Inc. 2665 Meadowpine Blvd. Mississauga, ON L5N 8C7 www.alcon.ca

More information

Chapter 32. Hearing, Speech, and Vision Problems. Copyright 2019 by Elsevier, Inc. All rights reserved.

Chapter 32. Hearing, Speech, and Vision Problems. Copyright 2019 by Elsevier, Inc. All rights reserved. Chapter 32 Hearing, Speech, and Vision Problems Copyright 2019 by Elsevier, Inc. All rights reserved. Lesson 32.1 Define the key terms and key abbreviations in this chapter. Describe the common ear, speech,

More information

What do I need to tell my doctor BEFORE I take this drug? If you have an allerg y to latanoprost or any other part of this drug.

What do I need to tell my doctor BEFORE I take this drug? If you have an allerg y to latanoprost or any other part of this drug. PATIENT & CAREGIVER EDUCATION Latanoprost Brand Names: US Xalatan; Xelpros Brand Names: Canada Monoprost; Xalatan What is this drug used for? It is used to treat glaucoma. It is used to lower high eye

More information

HIDROKORTIZON SA HLORAMFENIKOLOM (10 mg + 2 mg) / ml, eye drops, suspension

HIDROKORTIZON SA HLORAMFENIKOLOM (10 mg + 2 mg) / ml, eye drops, suspension PACKAGE LEAFLET: INFORMATION FOR THE USER HIDROKORTIZON SA HLORAMFENIKOLOM (10 mg + 2 mg) / ml, eye drops, suspension HYDROCORTISONE, CHLORAMPHENICOL This leaflet is a copy of the Summary of Product Characteristics

More information

Before prescribing DUOTRAV Eye Drops for you, your doctor will have examined the eye and decided that DUOTRAV Eye Drops is the right medicine.

Before prescribing DUOTRAV Eye Drops for you, your doctor will have examined the eye and decided that DUOTRAV Eye Drops is the right medicine. DUOTRAV Eye Drops travoprost 0.004% and timolol 0.5% Consumer Medicine Information What is in this Leaflet Read this leaflet carefully before you start to use This leaflet answers some common questions

More information

ILUVIEN 190 micrograms intravitreal implant in applicator (fluocinolone acetonide)

ILUVIEN 190 micrograms intravitreal implant in applicator (fluocinolone acetonide) ILUVIEN 190 micrograms intravitreal implant in applicator (fluocinolone acetonide) Read all of this information carefully before you are given this medicine because it contains important information for

More information

For patients with elevated intraocular pressure (IOP) in open-angle glaucoma (OAG) or ocular hypertension (OHT)

For patients with elevated intraocular pressure (IOP) in open-angle glaucoma (OAG) or ocular hypertension (OHT) The First and Only Preservative-Free Prostaglandin Once daily, preservative-free For patients with elevated intraocular pressure (IOP) in open-angle glaucoma (OAG) or ocular hypertension (OHT) Powerful

More information

MAXITROL* Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, USP 3.5 mg (as neomycin sulfate), 6000 IU/g, 0.

MAXITROL* Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, USP 3.5 mg (as neomycin sulfate), 6000 IU/g, 0. PRESCRIBING INFORMATION Pr MAXITROL* Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, USP 3.5 mg (as neomycin sulfate), 6000 IU/g, 0.1% w/w Pr MAXITROL* Neomycin and Polymyxin B

More information

IOPIDINE Eye Drops 0.5%

IOPIDINE Eye Drops 0.5% IOPIDINE Eye Drops 0.5% Apraclonidine hydrochloride CONSUMER MEDICINE INFORMATION What is in this leaflet Read this leaflet carefully before you start to use Iopidine Eye Drops. This leaflet answers some

More information

Cataract. What is a Cataract?

Cataract. What is a Cataract? Cataract What is a Cataract? We all have a lens in our eye. This is positioned just behind the iris, which is the coloured ring in the eye that gives your eye its colour. The lens function is to focus

More information

FROM CATARACTS TO CLARITY

FROM CATARACTS TO CLARITY Cathy Cataracts FROM CATARACTS TO CLARITY If you re 55 or older, you may have cataracts and not even know it. What You Need to Know Seeing Beyond the Symptoms Cataracts are one of the leading causes of

More information

CORNEAL CONDITIONS CORNEAL TRANSPLANTATION

CORNEAL CONDITIONS CORNEAL TRANSPLANTATION GENERAL INFORMATION CORNEAL CONDITIONS CORNEAL TRANSPLANTATION WHAT ARE CORNEAL CONDITIONS? The cornea is the clear outer layer of the eye. Shaped like a dome, it helps to protect the eye from foreign

More information

Instil one or two drops in the conjunctival sac(s) every three to four hours as needed.

Instil one or two drops in the conjunctival sac(s) every three to four hours as needed. NEW ZEALAND DATA SHEET 1. PRODUCT NAME NAPHCON FORTE Eye Drops 0.1% 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Naphcon Forte contains naphazoline hydrochloride 1.0 mg in 1 ml (0.1%). Excipient with known

More information

Glaucoma. College of Optometrists

Glaucoma. College of Optometrists Glaucoma Overview Glaucoma is a group of eye diseases in which the optic nerve, which connects your eye to your brain, is damaged by the pressure of the fluid inside your eye. This may be because the pressure

More information

DORZOLAMIDE/ TIMOLOL SANDOZ 20/5

DORZOLAMIDE/ TIMOLOL SANDOZ 20/5 TIMOLOL SANDOZ dorzolamide hydrochloride / timolol maleate eye drops Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about It does not contain all the available

More information

Revised: 07/2017. LUMIGAN (bimatoprost ophthalmic solution) 0.01% for topical ophthalmic use Initial U.S. Approval: 2001

Revised: 07/2017. LUMIGAN (bimatoprost ophthalmic solution) 0.01% for topical ophthalmic use Initial U.S. Approval: 2001 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LUMIGAN 0.01% safely and effectively. See full prescribing information for LUMIGAN 0.01%. LUMIGAN

More information

Cataract. What is a Cataract?

Cataract. What is a Cataract? Cataract What is a Cataract? We all have a lens in our eye. This is positioned just behind the iris, which is the coloured ring in the eye that gives your eye its colour. The lens s function is to focus

More information

Enjoying life with the KAMRA

Enjoying life with the KAMRA Enjoying life with the KAMRA inlay. Your aftercare guide to clearer reading vision. AFTERCARE guide NATURAL vision Natural Vision For Everyday Living Congratulations on your decision to get the KAMRA inlay!

More information

VOLTAREN OPHTHA Eye Drops 0.1%

VOLTAREN OPHTHA Eye Drops 0.1% VOLTAREN OPHTHA Eye Drops 0.1% Diclofenac sodium CONSUMER MEDICINE INFORMATION What is in this leaflet Read this leaflet carefully before you start to use Voltaren Eye Drops. This leaflet answers some

More information

8 USE IN SPECIFIC POPULATIONS Patients with Open-Angle Glaucoma or Ocular Hypertension

8 USE IN SPECIFIC POPULATIONS Patients with Open-Angle Glaucoma or Ocular Hypertension 3 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Isopto Carpine safely and effectively. See full prescribing information for Isopto Carpine. Isopto

More information

Chapter 42 1/8/2018. Key Terms. Hearing & Vision. Cerumen Deafness Hearing loss Tinnitus Vertigo

Chapter 42 1/8/2018. Key Terms. Hearing & Vision. Cerumen Deafness Hearing loss Tinnitus Vertigo Chapter 42 Hearing, Speech, & Vision Problems Key Terms Cerumen Deafness Hearing loss Tinnitus Vertigo Hearing & Vision Sight and hearing allow communication, learning, and moving about. Important for

More information

LATANOPROST / TIMOLOL SANDOZ

LATANOPROST / TIMOLOL SANDOZ LATANOPROST / TIMOLOL SANDOZ maleate Eye Drops Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about drops. It does not contain all the available information.

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. T-LO Timolol Ophthalmic Solution (0.25%, 0.

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. T-LO Timolol Ophthalmic Solution (0.25%, 0. READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr T-LO Timolol Ophthalmic Solution (0.25%, 0.5% w/v) Pr TIMOLOL MALEATE-EX Timolol Ophthalmic Gel Forming Solution

More information

Do not use Allergo-COMOD eye drops - if you are hypersensitive against sodium cromoglicate (Ph. Eur.) or one of the other ingredients.

Do not use Allergo-COMOD eye drops - if you are hypersensitive against sodium cromoglicate (Ph. Eur.) or one of the other ingredients. Allergo-COMOD eye drops 20 mg/ml eye drops Active substance: Sodium cromoglicate (Ph. Eur.) Read all of this leaflet carefully because it contains important information for you. This medicine is available

More information

Advice following Cataract surgery Eye clinic

Advice following Cataract surgery Eye clinic Advice following Cataract surgery Eye clinic 01935 475 122 yeovilhospital.nhs.uk The plastic shield The plastic shield over your eye can be removed the following morning. However, you should wear the shield

More information

IOPIDINE Eye Drops 0.5% Apraclonidine hydrochloride CONSUMER MEDICINE INFORMATION

IOPIDINE Eye Drops 0.5% Apraclonidine hydrochloride CONSUMER MEDICINE INFORMATION IOPIDINE Eye Drops 0.5% Apraclonidine hydrochloride CONSUMER MEDICINE INFORMATION What is in this leaflet Please read this leaflet carefully before you use Iopidine This leaflet answers some common questions

More information